Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Confocal Laser Endomicroscopy for Diagnosing Malignant Pleural Effusions (2018) Zirlik S, Hildner K, Rieker R, Neurath M, Fuchs F, Vieth M Journal article ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro (2018) Schmid R, Wolf K, Robering JW, Strauss S, Strissel P, Strick R, Rübner M, et al. Journal article Differences in the bacterial pattern of histamine intolerant patients (2018) Schink M, Tietz E, Dieterich W, Pinzer TC, Wirtz S, Neurath M, Zopf Y Conference contribution Crohn's Disease: Improved Treatment by Treat-to-Target-Concept Comment (2018) Atreya R Journal article Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018) Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al. Journal article Acoustic radiation force impulse (ARFI) elastography of the bowel wall as a possible marker of inflammatory activity in patients with Crohn's disease (2018) Görtz R, Lueke C, Wildner D, Vitali F, Neurath M, Strobel D Journal article Diagnostic ultrasound performed by a physician as a dialog (2018) Strobel D, Meng S Journal article, Editorial Contrast-Enhanced µCT for Visualizing and Evaluating Murine Intestinal Inflammation (2018) Jung D, Heiß R, Kramer V, Thoma OM, Regensburger A, Rascher W, Uder M, et al. Journal article Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps (2018) Roitsch S, Goesswein S, Neurath M, Leppkes M Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution